Home Online Features $275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case
$275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case
Press Releases
Fine, Kaplan, and Black, R.P.C.  
March 10, 2025

$275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case

PHILADELPHIA, March 10, 2025 /PRNewswire/ --

logo salamanca press

Salamanca Press

email salamanca press
Local & Social